SWEDEN, August 2 - Due to the serious security situation, there is greater need for control over who is attempting to enter Sweden and for what purposes. The Government has therefore decided to expand the mandate of the Police to intensify internal border …
Die Studie ergab, dass Obexelimab bei den meisten Patientinnen und Patienten mit aktiver IgG4-RD zu einer schnellen, deutlichen und anhaltenden klinischen Verbesserung, einschließlich einer vollständigen klinischen Remission führte Die Ergebnisse …
El estudio reveló que obexelimab produjo una mejora clínica rápida, fuerte y sostenida, incluyendo remisión clínica completa, en la mayoría de los pacientes con IgG4-RD activa Los resultados apoyan el desarrollo continuo de obexelimab para el tratamiento …
L'étude a montré que l'obéxélimab produisait une amélioration clinique rapide, forte et soutenue, y compris une rémission clinique complète, chez la plupart des patients atteints de ML-IgG4 active Les résultats soutiennent la poursuite du …
Studi menemukan obexelimab menghasilkan peningkatan klinis yang cepat, kuat, dan berkelanjutan, termasuk remisi klinis lengkap, di sebagian besar pasien dengan IgG4-RD aktif Hasil tersebut mendukung pengembangan berkesinambungan obexelimab untuk pengobatan …
治験では、オベキセリマブはほとんどの活動性IgG4-RD患者において、完全臨床寛解を含む、迅速かつ強力で持続的な臨床的改善を示した。 この結果は、IgG4-RDおよび潜在的に他のB細胞介在性自己免疫疾患の治療薬としてのオベキセリマブの開発継続を支持するものである。 マサチューセッツ州ウォルサム発, Aug. 03, 2023 (GLOBE NEWSWIRE) -- 免疫療法の開発･製品化におけるリーダーになることを目指す世界的なバイオ医薬品企業であるゼナス･バイオファーマは、ランセット･リウマトロジー誌に、 …
obexelimab, 대부분의 활동성 IgG4-RD 환자에서 기능적 완치 등 신속하고 강력하며 지속적인 임상적 개선 효과 보여 이번 연구 결과는 IgG4-RD 치료는 물론 기타 B세포 매개 자가면역질환 치료 잠재성도 보인 obexelimab의 지속적인 개발을 뒷받침 미국 매사추세츠주 월섬, Aug. 03, 2023 (GLOBE NEWSWIRE) -- 면역기반 치료제 개발 및 상용화에 매진하는 글로벌 바이오제약사인 Zenas BioPharma는 면역글로불린 …
การวิจัยพบว่า Obexelimab ให้ผลดีทางคลินิกอย่างรวดเร็ว ชัดเจน และต่อเนื่อง ซึ่งรวมถึงการหายจากโรคโดยสิ้นเชิงในผู้ป่วยส่วนใหญ่ที่มีอาการของโรค IgG4-RD ผลการวิจัยสนับสนุนให้มีการพัฒนา Obexelimab อย่างต่อเนื่องสำหรับการรักษาโรค IgG4-RD …
Kajian mendapati obexelimab menghasilkan peningkatan klinikal yang pesat, kuat dan berterusan, termasuk remisi klinikal lengkap, dalam kebanyakan pesakit yang menghidap IgG4-RD aktif Hasil menyokong pembangunan berterusan obexelimab untuk rawatan IgG4-RD …
Estudo revelou que o obexelimabe produziu melhora clínica rápida, forte e sustentada, incluindo remissão clínica completa, na maioria dos pacientes com IgG4-RD ativa Os resultados apoiam o desenvolvimento contínuo do obexelimabe para o tratamento de IgG4- …
研究发现，obexelimab 能使大多数活动性 IgG4-RD 患者的临床症状得到快速、有力和持续的改善，甚至达到完全临床缓解 研究结果支持继续开发 obexelimab 以治疗 IgG4-RD 和其他可能由 B 细胞介导的自身免疫性疾病 马萨诸塞州沃尔瑟姆, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma，一家致力于成为免疫疗法开发和商业化领导者的全球生物制药公司宣布，宣布其在期刊《柳叶刀风湿病学》上发表了一项 2 期研究的结果，该研究评估了 …
研究發現，obexelimab 在大多數患有活躍 IgG4-RD 的患者中產生了快速、有力和持續的臨床改善，包括完全臨床緩解 研究結果支持繼續開發 obexelimab 用於治療 IgG4-RD 和其他潛在的 B 細胞介導的自身免疫性疾病 麻薩諸塞州沃爾瑟姆, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma 是一家全球生物製藥公司，致力於成為免疫療法開發和商業化的領導者，該公司宣布《柳葉刀風濕病學》已發表一項評估 obexelimab 治療 IgG4 …
AirSept®, a leader in developing automotive solutions for complex repair problems, announces a new distribution partnership with Transtar Industries®. ATLANTA, GEORGIA, UNITED STATES, August 2, 2023 /EINPresswire.com/ -- AirSept®, a leader in …
August 2, 2023 Secretary to Visit Baltimore Farmers’ Market on August 6 BALTIMORE, MD (August 2, 2023) – It’s peak season for fresh, local produce in the state and a perfect time to celebrate national Farmers Market Week. Maryland Department of Agriculture …
Salt Lake City — The Endangered Species Act was enacted in 1973 to establish protections for fish, wildlife and plants in the U.S. It has prevented the extinction of hundreds of imperiled species and promoted the recovery of many others. With the ESA now …
New Addiction and Mental Health Facility Arrives in St. Lucie County FORT PIERCE, FLORIDA, UNITED STATES, August 2, 2023 /EINPresswire.com/ -- With a passion for providing exceptional care and support to those in need, Agape Behavioral Healthcare has …
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Triplepoint Venture Growth BDC Corp. (NYSE: TPVG) alleging that the Company violated federal securities laws. …
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that it is investigating allegations that Consensus Cloud Solutions, Inc. ("Consensus Cloud Solutions") (NASDAQ: CCSI) violated federal securities laws. CURRENT …
NEWPORT NEWS, Va., Aug. 02, 2023 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Newport News Shipbuilding (NNS) division authenticated the keel today for Virginia-class attack submarine Oklahoma (SSN 802). “We enjoy participating in Navy traditions like this one …
MIAMI, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Global Crossing Airlines Group, Inc. (JET: NEO; JET.B: NEO; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce the closing of the placement of US$35 million of Senior Secured Notes due 2029 (the “ …
05 days 23:31:55
